Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Protagonist Therapeutics Inc sell StockNews.com

Protagonist Therapeutics Inc
Start price
€76.50
18.10.23 / 50%
Target price
-
18.10.24
Performance (%)
-
End price
-
19.10.24
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Protagonist Therapeutics Inc 3.378% 3.378% 250.917%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by StockNews_com for this prediction

In the thread Protagonist Therapeutics Inc diskutieren

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat

StockNews.com 
0
Report Share
18.10.23 Sell -
In the thread Trading Protagonist Therapeutics Inc
Prediction Sell
Perf. (%) -
Target price
Change
Ends at 18.10.24

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

StockNews.com 
0
Report Share
19.10.24

Current prediction by StockNews_com for Protagonist Therapeutics Inc

sell
Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€41.80
31.05.25
-
31.05.26
83.01%
17.12.25

StockNews.com 
31.05.25 50%

Stopped prediction by StockNews_com for Protagonist Therapeutics Inc

sell
Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€76.50
30.09.23
-
30.09.24
-
01.10.24

StockNews.com 
30.09.23 50%